EyeWorld Weekly, September 19, 2025
Comments Off on EyeWorld Weekly, September 19, 2025
September 19, 2025
Browse articles from EyeWorld.org related to glaucoma. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
EyeWorld Weekly, September 5, 2025
➤ New designations granted to investigational treatment for retinal dystrophies ➤ Status update on BLA for bevacizumab for treatment of retinal diseases ➤ Acquisition news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, September 5, 2025
September 5, 2025
EyeWorld Weekly, August 29, 2025
➤ Accommodating lens implanted in first patient ➤ First patient dosed in Phase 2 trial investigating treatment for normal tension glaucoma ➤ Primary endpoint met in Phase 3 trial for glaucoma drop ➤ CE mark approvals ➤ Regenerative Medicine Advanced Therapy designation granted to investigational gene therapy for Stargardt disease ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, August 29, 2025
August 29, 2025
EyeWorld Weekly, August 22, 2025
➤ Phase 2 trial is the ‘first and only’ to show vision improvement for Stargardt disease ➤ IND accepted for retinal disease gene therapy and Phase 1/2 trial to begin ➤ First patients dosed in trial evaluating retinitis pigmentosa treatment ➤ LASIK alternative being researched ➤ Partnership news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, August 22, 2025
August 22, 2025
EyeWorld Weekly, August 8, 2025
➤ FDA approves aceclidine-based drop for presbyopia ➤ Long-term data supports efficacy of continuous wet AMD treatment ➤ First patient dosed in trial for drug eluting lacrimal canaliculus plug ➤ Acquisition news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, August 8, 2025
August 8, 2025
EyeWorld Weekly, July 25, 2025
➤ Topline Phase 2 results for drug treating neuropathic corneal pain ➤ Phase 3 blepharitis treatment doesn’t meet primary endpoint ➤ Study: therapeutic potential of collagen mimetic peptides for myopia ➤ FDA accepts NDA resubmission for dry eye therapy ➤ Partnership news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, July 25, 2025
July 25, 2025
Experience with virtual visual fields for glaucoma
Several physicians discussed the benefits they see with virtual reality visual fields in practice and the potential for artificial intelligence in glaucoma.
Comments Off on Experience with virtual visual fields for glaucoma
July 22, 2025
A continuous cycle of learning and innovation
Manjool Shah, MD, shared his thoughts on the topics of the Glaucoma articles: the often-asked question about the impact of lifestyle modifications, the increasingly critical imperative of sustainability in practices, and the rapidly advancing world of virtual visual fields and artificial intelligence.
Comments Off on A continuous cycle of learning and innovation
July 22, 2025
Sustainability in glaucoma
An emphasis on sustainability in healthcare has gained momentum in recent years. In this article, a group of glaucoma specialists who are experts in sustainability offered their perspectives on how to make meaningful changes in a clinical practice.
Comments Off on Sustainability in glaucoma
July 15, 2025
EyeWorld Weekly, July 11, 2025
➤ Results from second Phase 3 pivotal trial for presbyopia drop ➤ Interim Phase 2 data presented on DME, wet AMD treatment ➤ Phase 2 trial to investigate oral DME treatment ➤ First patient dosed in investigational cell therapy for photoreceptor diseases ➤ Phase 1 trial begins for minimally invasive dry AMD treatment ➤ Acquisitions and other company news ➤ ASCRS news and events
Comments Off on EyeWorld Weekly, July 11, 2025
July 11, 2025
